The latest trading session saw Novavax (NVAX) ending at $12.80, denoting a -0.85% adjustment from its last day's close. The stock trailed the S&P 500, which registered a daily gain of 0.28%. Meanwhile ...

Novavax Inc. closed $11.06 below its 52-week high ($23.86), which the company achieved on June 6th.

There's a new bulletin from Florida's surgeon general. Vaccine experts and historians interviewed for this article can’t ...

The Biden administration is about to announce free coronavirus tests for Americans, ahead of what is expected to be an active ...

MODERNA AND NOVAVAX...TARGETING THE NEWEST STRAINS OF THE CORONAVIRUS. YOU CAN GET THE COVID AND FLU SHOTS...AT THE SAME TIME. THE C-D-C RECOMMENDS A ONE-TIME R-S-V VACCINE...FOR PEOPLE 65 AND OLDER.

The US government plans to make more at-home Covid-19 tests available for free this month as the country heads into ...

Health care providers say Iowans should get their COVID-19, influenza and RSV vaccines in September or October ...

While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type ...

“COVID is still out there, and it’s still causing severe disease, and it’s still causing death at a much higher rate than the ...

Starting this month, Americans will be able to order free COVID-19 test kits that will be mailed to their homes. U.S.

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

The Food and Drug Administration (FDA) has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted.